Latest 10-K annual reports

NASDAQ
Duluth Holdings Inc. reported a significantly reduced net loss and increased Adjusted EBITDA for fiscal year 2025, despite a 9.8% decline in net sales.
NYSE ARCA
Bitwise Chainlink ETF (CLNK) has commenced trading on NYSE Arca, offering investors exposure to Chainlink, with a temporary fee waiver on initial assets.
NYSE ARCA
Bitwise XRP ETF details its inaugural operational period, reporting a net decrease in assets due to XRP price depreciation and outlining significant risks inherent in digital asset investments.
OTC.Pink
Strategic Student & Senior Housing Trust, Inc. reported a net loss of $4.3 million for 2025, with its estimated net asset value per share at $6.37 as of September 30, 2025, and continues to focus solely on senior housing properties.
NYSE ARCA
Bitwise Solana Staking ETF reported a significant net decrease in assets from operations and a 34.52% decline in NAV per share during its initial operating period, primarily due to a sharp depreciation in Solana's price.
Alpha Star Acquisition Corporation reports a significant working capital deficit and going concern doubt as its merger with OU XDATA GROUP remains unconsummated and it navigates post-Nasdaq delisting challenges.
OQX
ENB Financial Corp achieved record net income and strong profitability growth in 2025, driven by increased net interest income and a strategic acquisition.
OID
Security Federal Corporation reported a significant increase in net income available to common shareholders for 2025, driven by higher net interest income and a reversal of credit losses, despite a decrease in overall loan balances.
OQB
Oculus Inc. reported continued substantial losses and zero revenue for fiscal year 2025, raising significant doubts about its ability to continue as a going concern without substantial new financing.
NASDAQ
Union Bankshares, Inc. reported a significant increase in net income for 2025, driven by higher net interest income and strategic balance sheet repositioning, despite a challenging interest rate environment.
NASDAQ
Leapfrog Acquisition Corporation's 10-K filing outlines its blank check company structure, investment strategy in energy and infrastructure, and significant risks associated with SPACs.
OTC.Pink
Starwood Real Estate Income Trust, Inc. reported a GAAP net loss of $691.6 million for 2025, with share repurchase requests consistently exceeding monthly and quarterly limits.
OQX
Skyline Bankshares, Inc. reported a significant increase in net income for 2025, driven by robust loan portfolio growth and an improved net interest margin, following its 2024 acquisition of Johnson County Bank.
NASDAQ
First Seacoast Bancorp reported an increased net loss for fiscal year 2025, alongside a rise in non-performing loans and a breach of interest rate risk policy limits.
NYSE
Victoria's Secret & Co. reported a 5% increase in net sales to $6.553 billion for fiscal year 2025, but operating income declined to $271 million due to significant non-recurring charges, while advancing its 'Path to Potential' growth strategy.
NASDAQ
Milestone Pharmaceuticals Inc. announced FDA approval for its first commercial product, CARDAMYST nasal spray for PSVT, and is advancing etripamil for AFib-RVR while expanding international regulatory efforts.
NYSE
Dollar General reported a significant rebound in fiscal year 2025 with a 5.2% increase in net sales and a 34.4% rise in net income, driven by higher same-store sales and strategic initiatives.
NASDAQ
Aeva Technologies, a 4D LiDAR pioneer, announced a significant 99% revenue increase to $18.1 million in 2025, alongside continued net losses and strategic partnerships.
NASDAQ
Odysight.ai Inc. reported a 24% revenue decline and a 45% increase in net loss for 2025, driven by a strategic pivot from medical devices to vision-based AI solutions for predictive maintenance.
NYSE
SilverBox Corp IV, a SPAC, reported its annual results for 2025, highlighting a net income of $5.7 million and progress on its proposed business combination with Parataxis Holdings Inc.
AMEX
Strawberry Fields REIT, Inc. reported significant revenue and net income growth in 2025, driven by strategic acquisitions and increased rental income, despite rising interest and operating expenses.
NASDAQ
Strive, Inc. significantly expanded its bitcoin holdings to 13,628 by March 2026, driven by strategic acquisitions and purchases, despite reporting a substantial net loss of $393.6 million for fiscal year 2025.
NYSE
Spire Global reported a net income of $51.3 million for 2025, primarily driven by the $238.9 million sale of its maritime business, despite a 35% revenue decline and ongoing material weaknesses in internal controls.
NASDAQ
Eledon Pharmaceuticals' 2025 annual report details promising clinical trial results for tegoprubart in kidney and islet cell transplantation, alongside ongoing financial losses and the need for additional capital.
NASDAQ
Columbus Acquisition Corp (CAC) is progressing with its business combination with WISeSat.Space Holdings Corp. (Pubco) and WISeSat.Space Corp. (Target), despite significant shareholder redemptions and ongoing going concern considerations.
NYSE
Bakkt, Inc. reported a significant decline in revenue and increased net losses for fiscal year 2025, driven by client departures, despite completing a strategic transformation to focus on digital asset infrastructure and securing new capital.
AMEX
Avalon Holdings Corporation reported a net loss in 2025, driven by decreased golf and related operations revenue and ongoing legal expenses, despite improved working capital.
NovaBay Pharmaceuticals, Inc. has completed a significant business realignment, divesting its legacy pharmaceutical operations to focus on a blockchain-based digital asset strategy, primarily acquiring SKY tokens.
OQB
Netlist grew 2025 revenue 28% on AI-driven demand but recorded a net loss, extended its credit facility, raised equity, and flagged key risks including SK hynix supply expiry and ongoing IP litigation.
NASDAQ
Coeptis Therapeutics Holdings, Inc. reports a net loss of $12.28 million for 2025, driven by increased operating expenses, while strategically expanding its technology segment and pursuing a merger and spin-out of its biotech operations.